Literature DB >> 25026746

[Polymorphisms in the oxidative stress-related genes and cancer risk].

Anna Janicka, Jolanta Szymańska-Pasternak, Joanna Bober.   

Abstract

Oxidative damage induced by the generation of reactive oxygen species (ROS) is thought to be related to human cancer aetiology. Oxidative stress can result in DNA damage, including oxidized bases, formation of DNA adducts and DNA strand breaks, as well as lipid peroxidation, protein modification, membrane disruption and mitochondrial damage. The effect of reactive oxygen species is balanced by the antioxidant action ofnonenzymatic antioxidants (e.g. vitamins A, C, E, glutathione and flavonoids), as well as antioxidant enzymes. There are three main types of antioxidant defence enzymes: superoxide dismutases, catalase and glutathione peroxidases. A variety of cancer cells are known to have lower antioxidant enzyme activity when compared with their normal counterparts. Many studies have examined genetic variation in the genes coding for these enzymes and their relationship to cancer risk. Only a few genetic variants (single nucleotide polymorphisms--SNPs) in genes related to antioxidant defence were found to be associated with breast, prostate, lung, pancreatic, colorectal and bladder cancer. However, the results from these have been contradictory. Moreover, it is believed that environmental as well as genetic factors are implicated in the development of cancers, and consequently it is important to assess both genetic (including gene-gene association) and non-genetic (e.g. diet, supplementation, smoking and alcohol consumption) variability in the activities of defence enzymes in relation to cancer. In this review we focus on the biological function of antioxidant defence enzymes, and relationship between well-known SNPs in SOD1, SOD2, CAT, GPX1 and GPX4 genes and genetic susceptibility to cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 25026746

Source DB:  PubMed          Journal:  Ann Acad Med Stetin        ISSN: 1427-440X


  6 in total

Review 1.  Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.

Authors:  Sang Wook Kang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  There is no relationship between SOD2 Val-16Ala polymorphism and breast cancer risk or survival.

Authors:  Chengdi Wang; Yang Liu; Jian Zhou; Lei Ye; Nan Chen; Min Zhu; Yulin Ji
Journal:  Mol Clin Oncol       Date:  2017-08-14

Review 3.  Involvement of glutathione peroxidases in the occurrence and development of breast cancers.

Authors:  Man-Li Zhang; Hua-Tao Wu; Wen-Jia Chen; Ya Xu; Qian-Qian Ye; Jia-Xin Shen; Jing Liu
Journal:  J Transl Med       Date:  2020-06-22       Impact factor: 5.531

Review 4.  SOD2, a Potential Transcriptional Target Underpinning CD44-Promoted Breast Cancer Progression.

Authors:  Nouralhuda Alateyah; Ishita Gupta; Radoslaw Stefan Rusyniak; Allal Ouhtit
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

5.  A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer Survival.

Authors:  Jimmy Belotte; Nicole M Fletcher; Mohammed G Saed; Mohammed S Abusamaan; Gregory Dyson; Michael P Diamond; Ghassan M Saed
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

6.  Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence.

Authors:  Ana Lina Vodusek; Katja Goricar; Barbara Gazic; Vita Dolzan; Janez Jazbec
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.